Cyclopentolate Hcl Powder
NDC Package 57572-0721-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Cyclopentolate Hcl powders is a medication used before eye examinations (e.g., refraction exams). This formulation utilizes a powder delivery system. Marketed by Esteve Quimica Sa, this product is identified by NDC 57572-0721.

Identification & Billing

NDC Package Code
57572-0721-1
Package Description
25 kg in 1 DRUM
Product Code
57572-0721
11-Digit Billing Format
57572072101

Clinical Specifications

Proprietary Name
Cyclopentolate Hcl
Non-Proprietary Name
Cyclopentolate Hcl
Substance Name
Cyclopentolate Hydrochloride
Dosage Form
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Active Ingredient(s)
CYCLOPENTOLATE HYDROCHLORIDE 1 kg/kg
Usage Information
This medication is used before eye examinations (e.g., refraction exams). It belongs to a class of drugs known as anticholinergics. Cyclopentolate works by temporarily widening (dilating) the pupil of the eye and relaxing the muscles of the eye.

Regulatory & Marketing

Labeler Name
Esteve Quimica Sa
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date
05-12-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 57572-0721-1 identifies a specific commercial package of 25 kg in 1 drum of Cyclopentolate Hcl (UNFINISHED drug), a bulk ingredient labeled by Esteve Quimica Sa. This powder is formulated for use and contains cyclopentolate hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Esteve Quimica Sa on May 12, 2022. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used before eye examinations (e.g., refraction exams). It belongs to a class of drugs known as anticholinergics. Cyclopentolate works by temporarily widening (dilating) the pupil of the eye and relaxing the muscles of the eye.

How is this Esteve Quimica Sa product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 57572072101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
57572-0721-1
11-Digit CMS (5-4-2)
57572-0721-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.